OM

Opaleye Management Portfolio holdings

AUM $494M
1-Year Est. Return 68.17%
This Quarter Est. Return
1 Year Est. Return
+68.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$600M
AUM Growth
+$162M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
57
New
Increased
Reduced
Closed

Top Buys

1
+$17.2M
2
+$16.4M
3
+$13.7M
4
DNA icon
Ginkgo Bioworks
DNA
+$6.68M
5
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
+$3.56M

Top Sells

1
+$10.5M
2
+$7.26M
3
+$7.19M
4
CYTK icon
Cytokinetics
CYTK
+$6.5M
5
NTLA icon
Intellia Therapeutics
NTLA
+$4.88M

Sector Composition

1 Healthcare 98.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$179M 29.92%
3,990,000
2
$53.3M 8.89%
2,280,000
3
$43.7M 7.29%
5,025,000
-282,500
4
$30.9M 5.16%
1,255,000
+700,000
5
$27M 4.51%
8,770,000
+5,315,000
6
$26.2M 4.37%
500,000
-15,000
7
$23M 3.83%
395,276
+27,776
8
$18.1M 3.02%
1,237,500
+135,000
9
$17M 2.83%
1,698,142
+1,373,142
10
$16.7M 2.78%
2,780,000
+385,000
11
$13.9M 2.33%
522,500
-57,500
12
$11.8M 1.97%
541,437
-14,263
13
$11.2M 1.87%
1,320,000
-360,000
14
$9.71M 1.62%
85,000
15
$9.44M 1.57%
420,000
+1,072
16
$9.34M 1.56%
1,893,660
+313,660
17
$8.58M 1.43%
2,567,990
-77,010
18
$6.97M 1.16%
3,815,000
-205,000
19
$6.68M 1.11%
+820,202
20
$6.65M 1.11%
353,500
-38,500
21
$6.62M 1.1%
250,000
22
$6.55M 1.09%
64,000
+4,700
23
$5.56M 0.93%
335,000
+20,000
24
$5.13M 0.86%
404,100
-7,900
25
$4.72M 0.79%
105,000
1
2 3